These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 18074519)

  • 1. [Reporting system for adverse drug reactions and infections].
    Hashiguchi M; Mochizuki M
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():67-72. PubMed ID: 18074519
    [No Abstract]   [Full Text] [Related]  

  • 2. [Reporting system for adverse drug reactions and infections].
    Hashiguchi M; Mochizuki M
    Nihon Rinsho; 2012 Aug; 70 Suppl 6():29-35. PubMed ID: 23156483
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacists' role in reporting adverse drug reactions in an international perspective.
    van Grootheest K; Olsson S; Couper M; de Jong-van den Berg L
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):457-64. PubMed ID: 15269929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interview -- drug legislation -- reporting unexpected adverse drug reactions].
    Ludwig WD
    Pneumologie; 2009 Sep; 63(9):479-80. PubMed ID: 19764017
    [No Abstract]   [Full Text] [Related]  

  • 5. [The safety of pharmacotherapy in the light of monitoring adverse drug reaction].
    Jabłecka A; Korzeniowska K
    Przegl Lek; 2010; 67(10):1091-2. PubMed ID: 21360968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug monitoring in Tunisia: organization and objectives].
    Daghfous R; Elaidi S; Loueslati MH; Srairi S; Lakhal M; Belkahia C
    Tunis Med; 1994 Feb; 72(2):83-6. PubMed ID: 7974826
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug monitoring].
    Royer RJ
    Bull Soc Sci Med Grand Duche Luxemb; 1995; 132(3):33-4. PubMed ID: 8665623
    [No Abstract]   [Full Text] [Related]  

  • 8. New EU drug safety committee ends national reporting of drug reactions.
    Watson R
    BMJ; 2012 Jul; 345():e4690. PubMed ID: 22777561
    [No Abstract]   [Full Text] [Related]  

  • 9. Failure to recognize adverse drug reactions despite warnings.
    Griffin JP
    Adverse Drug React Toxicol Rev; 1999 Mar; 18(1):1-3. PubMed ID: 10401518
    [No Abstract]   [Full Text] [Related]  

  • 10. Presenting the case for an immunization safety surveillance system.
    Darwish AA
    Bull World Health Organ; 2000; 78(2):216. PubMed ID: 10743287
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyponatremia in relation to treatment with antidepressants: a survey of reports in the World Health Organization data base for spontaneous reporting of adverse drug reactions.
    Spigset O; Hedenmalm K
    Pharmacotherapy; 1997; 17(2):348-52. PubMed ID: 9085327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug safety: reporting systems for the general public.
    Raine JM
    BMJ; 2012 Aug; 345():e4916. PubMed ID: 22872709
    [No Abstract]   [Full Text] [Related]  

  • 13. Monitoring vaccine safety during an influenza pandemic.
    Iskander J; Haber P; Herrera G
    Yale J Biol Med; 2005 Oct; 78(5):265-75. PubMed ID: 17132333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New FDA regulation to improve safety reporting in clinical trials.
    Sherman RB; Woodcock J; Norden J; Grandinetti C; Temple RJ
    N Engl J Med; 2011 Jul; 365(1):3-5. PubMed ID: 21651388
    [No Abstract]   [Full Text] [Related]  

  • 15. Improving the reporting of adverse drug reactions in the hospital setting.
    Pushkin R; Frassetto L; Tsourounis C; Segal ES; Kim S
    Postgrad Med; 2010 Nov; 122(6):154-64. PubMed ID: 21084792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Classification and profile of adverse drug effects].
    Cordonnier M
    Bull Soc Belge Ophtalmol; 2007; (304):15-6. PubMed ID: 17718223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The WHO Programme for International Drug Monitoring, its database, and the technical support of the Uppsala Monitoring Center.
    Lindquist M; Edwards IR
    J Rheumatol; 2001 May; 28(5):1180-7. PubMed ID: 11361210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The incidence of drug side effects with reference to organ systems. Experience of the spontaneous reporting system of the Swiss Drug Side Effect Center and Comprehensive Drug Monitoring].
    Kuhn M; Hartmann K; Maibach R; Capaul R; Gartmann JC
    Ther Umsch; 1993 Jan; 50(1):8-12. PubMed ID: 8378869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extraction of adverse drug effects from clinical records.
    Aramaki E; Miura Y; Tonoike M; Ohkuma T; Masuichi H; Waki K; Ohe K
    Stud Health Technol Inform; 2010; 160(Pt 1):739-43. PubMed ID: 20841784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Japan plans improved monitoring of new drugs.
    Lamar J
    BMJ; 2000 Jun; 320(7249):1560. PubMed ID: 10845957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.